ECSP16005679A - Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio - Google Patents

Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Info

Publication number
ECSP16005679A
ECSP16005679A ECIEPI20165679A ECPI201605679A ECSP16005679A EC SP16005679 A ECSP16005679 A EC SP16005679A EC IEPI20165679 A ECIEPI20165679 A EC IEPI20165679A EC PI201605679 A ECPI201605679 A EC PI201605679A EC SP16005679 A ECSP16005679 A EC SP16005679A
Authority
EC
Ecuador
Prior art keywords
paracetamol
celecoxib
inflammatory pain
treatment
synergistic combination
Prior art date
Application number
ECIEPI20165679A
Other languages
English (en)
Spanish (es)
Inventor
Medellin Jorge Fernando Cantú
Original Assignee
More Pharma Corp S De R L De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52279400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP16005679(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by More Pharma Corp S De R L De C V filed Critical More Pharma Corp S De R L De C V
Publication of ECSP16005679A publication Critical patent/ECSP16005679A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ECIEPI20165679A 2013-07-11 2016-02-11 Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio ECSP16005679A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2013/055710 WO2015004505A1 (fr) 2013-07-11 2013-07-11 Combinaison synergique de paracétamol/célécoxib pour le traitement de douleur inflammatoire

Publications (1)

Publication Number Publication Date
ECSP16005679A true ECSP16005679A (es) 2017-08-31

Family

ID=52279400

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI20165679A ECSP16005679A (es) 2013-07-11 2016-02-11 Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Country Status (8)

Country Link
CL (1) CL2015003211A1 (fr)
CR (1) CR20160021A (fr)
CU (1) CU24440B1 (fr)
DO (1) DOP2016000008A (fr)
EC (1) ECSP16005679A (fr)
MX (1) MX366118B (fr)
PE (2) PE20170305A1 (fr)
WO (2) WO2015004505A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11147780B2 (en) * 2020-02-24 2021-10-19 Algia Pharma, Llc Multidrug pain management package

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070251A1 (fr) * 2002-02-19 2003-08-28 Adcock Ingram Limited Combinaisons pharmaceutiques d'inhibiteurs de cox-2 et d'opiaces
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
WO2015004634A3 (fr) 2015-04-09
CR20160021A (es) 2016-04-08
CU24440B1 (es) 2019-09-04
MX366118B (es) 2019-06-27
MX2015013911A (es) 2015-12-08
PE20160239A1 (es) 2016-05-13
CU20160002A7 (es) 2016-06-29
DOP2016000008A (es) 2016-03-15
CL2015003211A1 (es) 2016-04-29
WO2015004634A2 (fr) 2015-01-15
PE20170305A1 (es) 2017-04-21
WO2015004505A1 (fr) 2015-01-15

Similar Documents

Publication Publication Date Title
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2016002516A1 (es) “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CU20150163A7 (es) DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
CO6700827A2 (es) Corticosteroides para el tratamiento de dolor de articulaciones
PE20180399A1 (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
CL2016000313A1 (es) Compuestos de benzoxaborol tricíclicos y usos de los mismos
CL2015002433A1 (es) Imidazopiridazinas sustituidas
NI201700078A (es) Pirazolpiridinaminas
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
CO2018012180A2 (es) Métodos de tratamiento para enfermedades colestásicas y fibróticas
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
CL2016001546A1 (es) Composición para el cuidado oral que comprende serina y al menos una sal de zinc.
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
CL2015001225A1 (es) Agente terapéutico para trastornos queratoconjuntivos.
ECSP16005679A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
CL2016000397A1 (es) Tratamiento contra el cáncer
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica